ANNX
NASDAQ · Biotechnology
Annexon Inc
$4.18
-0.04 (-0.95%)
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Price Target
Analyst Price Target
+876.3% upside
Low Target
$23.52
Average Target
$40.81
High Target
$51.70
Current Price
$4.18
Current
$4.18
$4.18
Target
$40.81
$40.81
$23.52
$40.81 avg
$51.70
Scenario Analysis
Bear Case
$23.52
462.7%
Low target
Base Case
$40.81
+876.3%
Avg target
Bull Case
$51.70
+1,136.8%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$7.18
-41.8% from high
52-Week Low
$2.50
+67.2% from low
Target vs 52W High
$40.81
+468.4% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -2.9% |
| AMGN | Hold | 43 | 47% | $190.87 | -53.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +137.6% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -14.9% |
| REGN | Buy | 38 | 68% | $76.80 | -90.4% |
| MRNA | Hold | 30 | 37% | $149.45 | -18.1% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -63.4% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -40.8% |